PolTREG S.A.

🗓 Founded 2015👥 4 employees💰 Last funded Dec 2015
Biotechnology Research🌐 poltreg.tech
Website LinkedIn
PolTREG was established as a spin-off from the Medical University of Gdańsk in order to develop and commercialize patented TREG method. Due to positive results of clinical trials of TREG method at the University Clinical Center in Gdansk, sharing this breakthrough therapy with as many patients as possible became the main focus of the company. During nearly two years of preparation prior to company’s establishment, business model, commercialization strategy and legal protection of invention were developed together with the University and research team. In July 2015 company was officially established with participation of University’s special purpose vehicle (SPV), R&D team – patent creators and implementation team, experienced in securing external funding and managing innovative projects. PolTREG is the only entity entitled to implementing the research findings in the area of T-regulatory lymphocytes and using their growth method for clinical use.
1
Total investors
1
Early stage
0
Mid stage
0
Late stage
2015
Founded

Investors

1 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
Poland
1
Frequently asked questions
Who invested in PolTREG S.A.?
PolTREG S.A. has 1 investors on record on gritt.io, including 1 early-stage backers.
When did PolTREG S.A. last raise funding?
The most recent investment in PolTREG S.A. recorded on gritt.io was in December 2015.
When was PolTREG S.A. founded?
PolTREG S.A. was founded in 2015.
What industry is PolTREG S.A. in?
PolTREG S.A. operates in Biotechnology Research. Find similar Biotechnology Research investors on gritt.io.